Konrad Palka
Chief Executive Officer bei PHARMENA S.A.
Profil
Konrad Palka is currently the Chairman-Management Board at PHARMENA SA since 2002 and the President, Secretary, Treasurer & Director at Cortria Corp.
He previously worked as the Director-Sales & Marketing at BRE Banku SA, Skarbiec Emerytura OFE, and Bank Austria Creditanstalt Poland SA. Mr. Palka graduated from the University of Lodz.
Aktive Positionen von Konrad Palka
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMENA S.A. | Chief Executive Officer | 12.11.2002 |
Cortria Corp.
 Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | President | - |
Ehemalige bekannte Positionen von Konrad Palka
| Unternehmen | Position | Ende |
|---|---|---|
BRE Banku SA
 BRE Banku SA Investment Banks/BrokersFinance BRE Banku SA provides brokerage services. The private company is based in Warsaw, Poland. | Sales & Marketing | - |
| Skarbiec Emerytura OFE | Sales & Marketing | - |
Bank Austria Creditanstalt Poland SA
 Bank Austria Creditanstalt Poland SA Major BanksFinance Bank Austria Creditanstalt Poland SA is an international commercial bank. The company is based in Warsaw, Austria. | Corporate Officer/Principal | - |
Ausbildung von Konrad Palka
| University of Lodz | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARMENA S.A. | Consumer Non-Durables |
| Private Unternehmen | 4 |
|---|---|
Cortria Corp.
Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | Health Technology |
Bank Austria Creditanstalt Poland SA
Bank Austria Creditanstalt Poland SA Major BanksFinance Bank Austria Creditanstalt Poland SA is an international commercial bank. The company is based in Warsaw, Austria. | Finance |
BRE Banku SA
BRE Banku SA Investment Banks/BrokersFinance BRE Banku SA provides brokerage services. The private company is based in Warsaw, Poland. | Finance |
| Skarbiec Emerytura OFE | Finance |
